Harvard Bio and PerkinElmer Name COOs; Compugen CEO to Step Down; TIGR s Fraser, Salzberg Become AAAS Fellows; and Others

Sue Luscinski has been promoted from CFO to COO of Harvard Bioscience, a new position, HBIO said last week. Bryce Chicoyne has been hired as new CFO.

John Murphy has been promoted to executive vice president and COO of PerkinElmer, a new position, the company said yesterday. Most recently, he was president of PE's optoelectronics business. In this position, he was replaced by John Roush, who used to be vice president of product management and global sales and customer operations for optoelectronics.

Also, Robert Friel has been promoted to executive vice president for business development and CFO. He has been PE's CFO since 1999.

Andras Guttman has joined the scientific advisory board of EGene, the Irvine, Calif.-based company said yesterday. He is a professor at the Universityof Innsbruckin Austria, where he leads the Horvarth Laboratory of Bioseparation Sciences. Guttman holds a PhD and an undergraduate degree in chemical engineering from VeszpremUniversityin Hungary.

Eric Fung has been promoted to vice president for clinical and medical affairs for the diagnostics division of Ciphergen Biosystems, the company said on Monday. Simon Shorter has become vice president of business development.

Richard Riegel has joined life science consulting firm Taratec as vice president of sales and business development. Riegel comes to Taratec from IBM, where he served most recently as vice president of solutions marketing for IBM Healthcare and Life Sciences and previously as general manager of the company's Pharmaceutical Industry practice. Prior to joining IBM, Riegel spent eight years at First Consulting Group in a number of positions, including managing director of the company's Life Sciences Division.

Thomas Adams has joined the board of directors of Xenomics, the New York-based company said yesterday. He is the fonder and CEO of Leucadia Technologies, a company working on ultra-sensitive detection of proteins for diagnostic purposes. Adamswas also a co-founder, chairman, and CEO of Gen Probe and a founder of Genta.

Björn Ekström has become CEO of Olink Bioscience, a Swedish company focusing on protein analysis technology that was founded in September, Olink said last week. Previously, he was EVP and head of R&D at Pyrosequencing. He also held several positions within R&D at Amersham Biosciences and Pharmacia Biotech.

Mor Amitai will step down as president and CEO of Compugen by the end of 2005, the Tel Aviv-based company said on Sunday. Compugen is now searching for a new CEO with more experience in pharmaceutical product development and commercialization. Amitai, who has been heading Compugen for seven years, said he plans to "maintain an active role" in the company, albeit in a different capacity.

Holger Reithinger will join German Global Life Science Ventures as principal in the private-equity firm's Munichoffices, the company said last month. Previously, Reithinger was director of 3i Germany's healthcare practices, overseeing investments in Europe.

Kurt Vedder joined the venture capital firm De Novo Ventures of Menlo Park, Calif., as director of strategic business development and research, the company said last month. Previously, Vedder was a business development manager for Guidant and Medtronic. De Novo invests in early-stage life-sciences technologies and medical devices.

Jason Van Tassel was named to the scientific advisory board of CalbaTech of Irvine, Calif., the company said last week. Van Tassel is a physician with a practice specializing in plastic surgery in Los Angeles. Previously, he was a researcher with Hybritech. CalbaTech is an early-stage company focusing on the acquisition of molecular and cellular biology technology platforms in the USand the UK.

Claire Fraser and Steven Salzberg have become fellows of the American Association for the Advancement of Science, the Institute for Genome Research said last week. Fraser, who is president of TIGR, was honored for her efforts in the field of genomics, particularly in the sequencing and analysis of microbial genomes. Salzberg, TIGR's senior bioinformatics director, was cited for new algorithms in bioinformatics, particularly for prokaryotic gene finding algorithms, and for novel contributions to the analysis of multiple prokaryotic and eukaryotic genomes.

Kilmer McCully has joined the science advisory board of GenoMed, the St. Louis-based company said last week. He is chief of pathology and laboratory medicine and director of the Boston Area Consolidated Laboratories at the Veterans Affairs Medical Center in West Roxbury, Massachusetts. He is also an associate clinical professor of pathology at Harvard Medical School.